Summary
- Current Price
- As of today, RGC price is $5.45, up +4.01% on
- Current Price All-Time High
- RGC price is currently -98.56% below its historical high of $379.50 set on
- Market Cap
- RGC current market cap is $3B, down -57.09% year-over-year
- Revenue
- RGC current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RGC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Regencell Bioscience Holdings L |
| Ticker | NASDAQ: RGC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Hong Kong |
| IPO | |
| Indexes | Not included |
| Website | regencellbioscience.com |
| Employees | 10 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $5.45 | |
| Price, 1D Change | +4.01% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.42 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$0.01 | |
| EPS, 1Y Change | +97.82% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 38:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$0.01 | |
| EPS Estimate | - | |
| EPS Est. Change | - | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $5.45 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.33 | - | |
| - | -$0.01 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -57.09% | |
| Price, 3Y | +1,280.80% | |
| Market Cap, 1Y | -57.09% | |
| Market Cap, 3Y | +1,280.80% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +97.82% | |
| EPS, 3Y | +98.77% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $5.45 | |
| SMA 200 | $20.56 | |
| SMA 50 | $8.86 | |
| EMA 200 | $17.13 | |
| EMA 50 | $9.58 | |
| MACD | -$0.96 | |
| Beta | 1.42 | |
| ATR | $0.74 | |
| 14-Day RSI | 37.23 | |
| 10-Day Volatility | 54.45% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$0.01 | |
| Gross Profit | -$392.70K | |
| - | ||
| Operating Income | -$3.77M | |
| - | ||
| Net Income | -$3.58M | |
| - | ||
| EBITDA | -$3.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.11 | |
| 7.39 | ||
| 7.39 | ||
| - | ||
| - | ||
| 1,798.67 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 2,210.11 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $4.86M | |
| $4.90M | ||
| $5.76M | ||
| $4.90M | ||
| $895.30K | ||
| $663.70K | ||
| Total Debt | $544.40K | |
| $312.80K | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $3.58M | ||
| $3.38M | ||
| $392.70K | ||
| $0.00 | ||
| $392.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$3.11M | ||
| $2.69M | ||
| $0.00 | ||
| Capex | $152.70K | |
| -$3.27M |
Recent analyst updates
No data
Analyst sentiment
Institutional ownership
Screeners with RGC
FAQ
- What is the ticker symbol for Regencell Bioscience Holdings L?
- The ticker symbol for Regencell Bioscience Holdings L is NASDAQ:RGC
- Does Regencell Bioscience Holdings L pay dividends?
- No, Regencell Bioscience Holdings L does not pay dividends
- What sector is Regencell Bioscience Holdings L in?
- Regencell Bioscience Holdings L is in the Healthcare sector
- What industry is Regencell Bioscience Holdings L in?
- Regencell Bioscience Holdings L is in the Specialty & Generic Drug Manufacturers industry
- What country is Regencell Bioscience Holdings L based in?
- Regencell Bioscience Holdings L is headquartered in Hong Kong
- When did Regencell Bioscience Holdings L go public?
- Regencell Bioscience Holdings L initial public offering (IPO) was on July 16, 2021
- Is Regencell Bioscience Holdings L in the S&P 500?
- No, Regencell Bioscience Holdings L is not included in the S&P 500 index
- Is Regencell Bioscience Holdings L in the NASDAQ 100?
- No, Regencell Bioscience Holdings L is not included in the NASDAQ 100 index
- Is Regencell Bioscience Holdings L in the Dow Jones?
- No, Regencell Bioscience Holdings L is not included in the Dow Jones index
- When was Regencell Bioscience Holdings L last earnings report?
- Regencell Bioscience Holdings L's most recent earnings report was on June 15, 2026
- When does Regencell Bioscience Holdings L report earnings?
- The next expected earnings date for Regencell Bioscience Holdings L is October 28, 2026
Data Sources & References
- RGC Official Website www.regencellbioscience.com
- RGC Profile on Yahoo Finance finance.yahoo.com/quote/RGC
- RGC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgc